Ben Haynor
Stock Analyst at Lake Street
(1.29)
# 3,625
Out of 5,172 analysts
44
Total ratings
39.62%
Success rate
-14.08%
Average return
Main Sectors:
Stocks Rated by Ben Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMCI Treace Medical Concepts | Maintains: Buy | $7.5 → $7 | $1.24 | +464.52% | 2 | Mar 2, 2026 | |
| BFLY Butterfly Network | Maintains: Buy | $4 → $5.5 | $3.97 | +38.54% | 2 | Jan 20, 2026 | |
| PIII P3 Health Partners | Maintains: Buy | $20 → $13 | $2.90 | +331.03% | 2 | Nov 17, 2025 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $24 → $32 | $26.10 | +22.61% | 2 | Nov 4, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $37 → $34 | $16.52 | +105.81% | 2 | Oct 10, 2025 | |
| SRTS Sensus Healthcare | Maintains: Buy | $13 → $6 | $3.87 | +55.04% | 5 | Aug 8, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $15 → $9.5 | $10.54 | -9.87% | 4 | Jul 29, 2025 | |
| ATEC Alphatec Holdings | Assumes: Buy | $18 | $12.37 | +45.51% | 1 | Jun 16, 2025 | |
| LFWD Lifeward | Maintains: Buy | $54 → $48 | $6.74 | +612.17% | 2 | Mar 11, 2025 | |
| MYO Myomo | Maintains: Buy | $7 → $7.5 | $0.71 | +957.23% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.9 → $2.9 | $0.63 | +361.49% | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $5.06 | +113.44% | 3 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $0.85 | +2,086.76% | 1 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.41 | +501.66% | 1 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.25 → $2.2 | $0.78 | +182.05% | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $82 | $7.99 | +926.28% | 3 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5.55 | $1.15 | +382.61% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.15 → $4.75 | $1.81 | +162.43% | 3 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $0.62 | +3,599.19% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,375 | $2.09 | +65,689.47% | 1 | Jun 26, 2020 |
Treace Medical Concepts
Mar 2, 2026
Maintains: Buy
Price Target: $7.5 → $7
Current: $1.24
Upside: +464.52%
Butterfly Network
Jan 20, 2026
Maintains: Buy
Price Target: $4 → $5.5
Current: $3.97
Upside: +38.54%
P3 Health Partners
Nov 17, 2025
Maintains: Buy
Price Target: $20 → $13
Current: $2.90
Upside: +331.03%
Tactile Systems Technology
Nov 4, 2025
Maintains: Buy
Price Target: $24 → $32
Current: $26.10
Upside: +22.61%
OrthoPediatrics
Oct 10, 2025
Maintains: Buy
Price Target: $37 → $34
Current: $16.52
Upside: +105.81%
Sensus Healthcare
Aug 8, 2025
Maintains: Buy
Price Target: $13 → $6
Current: $3.87
Upside: +55.04%
Ekso Bionics Holdings
Jul 29, 2025
Maintains: Buy
Price Target: $15 → $9.5
Current: $10.54
Upside: -9.87%
Alphatec Holdings
Jun 16, 2025
Assumes: Buy
Price Target: $18
Current: $12.37
Upside: +45.51%
Lifeward
Mar 11, 2025
Maintains: Buy
Price Target: $54 → $48
Current: $6.74
Upside: +612.17%
Myomo
Jul 9, 2024
Maintains: Buy
Price Target: $7 → $7.5
Current: $0.71
Upside: +957.23%
Mar 20, 2024
Maintains: Buy
Price Target: $1.9 → $2.9
Current: $0.63
Upside: +361.49%
Mar 11, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $5.06
Upside: +113.44%
Oct 2, 2023
Initiates: Buy
Price Target: $19
Current: $0.85
Upside: +2,086.76%
Sep 8, 2023
Initiates: Buy
Price Target: $15
Current: $2.41
Upside: +501.66%
Aug 15, 2023
Maintains: Buy
Price Target: $3.25 → $2.2
Current: $0.78
Upside: +182.05%
Aug 11, 2023
Maintains: Buy
Price Target: $109 → $82
Current: $7.99
Upside: +926.28%
May 19, 2023
Maintains: Buy
Price Target: $10 → $5.55
Current: $1.15
Upside: +382.61%
May 17, 2023
Maintains: Buy
Price Target: $5.15 → $4.75
Current: $1.81
Upside: +162.43%
Feb 17, 2023
Initiates: Buy
Price Target: $23
Current: $0.62
Upside: +3,599.19%
Jun 26, 2020
Initiates: Buy
Price Target: $1,375
Current: $2.09
Upside: +65,689.47%